Skip to main content
Demetrios Braddock, MD, Pathology, New Haven, CT

DemetriosThomasBraddockMD

Pathology New Haven, CT

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor/Yale University

Dr. Braddock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Braddock's full profile

Already have an account?

  • Office

    310 CEDAR STREET
    BML-165
    New Haven, CT 06510
    Phone+1 203-737-1278

Summary

  • I am a physician/scientist, at Yale, where I have led an independently funded laboratory and practiced hematopathology since 2004. My laboratory's focus is the study severe poorly addressed human disease with an emphasis on the elucidation of disease pathogenesis to unveil therapeutic targets. I am particularly interested in rare diseases of children, and in the design and engineering of novel biologics to modulate disease outcome.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 2000
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1996
  • University of Chicago
    University of ChicagoPh.D., Biochemistry, 1994
  • University of Chicago
    University of ChicagoA.B., Chemistry, 1988

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2012 - 2026
  • CT State Medical License
    CT State Medical License 2004 - 2025
  • NY State Medical License
    NY State Medical License 2012 - 2025
  • CA State Medical License
    CA State Medical License 2010 - 2023
  • MD State Medical License
    MD State Medical License 2012 - 2022
  • NJ State Medical License
    NJ State Medical License 2012 - 2021
  • GA State Medical License
    GA State Medical License 2012 - 2020
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Hematopathology
  • Join now to see all

Awards, Honors, & Recognition

  • Commissioned Officer U.S. Public Health Service Home (USPHS)
  • Dean's List University of Chicago
  • Emerging Leaders' Program Yale New Haven Hospital (YNHH), Yale School of Management, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • "In vivo correction of anaemia in Beta-thalassemic mice by gammaPNA-mediated gene editing with nanoparticle delivery"  
    Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, Lu YC, Bhunia DC, Manna A, Greiner DL, Brehm MA, Cheng CJ, Lopez-Giraldez F, Ricciardi A, Beloor J, K..., Nature Communications, 1/26/2016
  • "pHLIP® targeting of PNA to silence MicroRNA in tumors"  
    Cheng, C.J., Bahal, R., Babar, I.A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D.T., Glazer, P.M., Engelman, D.M., Saltzman, W.M., Slack, F.J., Nature, 1/5/2015
  • "ENPP1-Fc Fusion Protein Prevents Mortality and Vascular Calcifications in Rodent Model of Generalized Calcification of Infancy"  
    Albright, R.A., Stabach, P., Cao, W., Kavanagh, D., Mullen, I., Braddock, A.A., Covo M.S., Tehan, M., Yang, G., Cheng, Z., Bouchard, K., Zhao-Xue, Y., Thorn, S., Wang,..., Nature Communications, 1/1/2015
  • Join now to see all

Books/Book Chapters

Press Mentions

  • Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
    Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAugust 15th, 2022
  • Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business Highlights
    Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business HighlightsMay 10th, 2022
  • Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at Yale
    Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at YaleMay 21st, 2021
  • Join now to see all

Grant Support

  • ENPP1 regulation of mammalian bone massNIH/NIAMS2022–2027
  • Targeting NETs in Human DiseaseBlavatnik Foundation2021–2023
  • Enzyme Therapy for CKD-MDB: Breaking the Barrier of Vascular CalcificationNIH/NIDDK2020–2023
  • Discovery, Validation, and Translational Development of Biologic Therapeutics for Ectopic Calcification DisordersInozyme Pharma2017–2023
  • Non – Nuclease Based Gene Editing for Hutchinson-Gilford ProgeriaNIH/NIAID2020–2022
  • Structure-Function Studies On PUF60 &On Npp4National Center For Research Resources2011
  • Locating The Regions Of An Adml 3'Intron RNA Analogue Bound To PUF60 RrmsNational Center For Research Resources2011
  • Structure Of The Prometastatic Enzyme AutotaxinNational Center For Research Resources2010
  • 3D Determination Of An Npase PhosphodiesteraseNational Center For Research Resources2008–2010
  • Fir:Fuse ComplexNational Center For Research Resources2006

Industry Relationships

  • Founder, SAB member, and Consultant, Inozyme Phama2017 - Present